348 related articles for article (PubMed ID: 10903978)
1. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
[TBL] [Abstract][Full Text] [Related]
2. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
Takanaga H; Ohnishi A; Yamada S; Matsuo H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
J Pharmacol Exp Ther; 2000 Apr; 293(1):230-6. PubMed ID: 10734174
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
Takanaga H; Ohnishi A; Matsuo H; Sawada Y
Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
[TBL] [Abstract][Full Text] [Related]
4. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.
Paine MF; Widmer WW; Pusek SN; Beavers KL; Criss AB; Snyder J; Watkins PB
Am J Clin Nutr; 2008 Apr; 87(4):863-71. PubMed ID: 18400708
[TBL] [Abstract][Full Text] [Related]
6. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
Honda Y; Ushigome F; Koyabu N; Morimoto S; Shoyama Y; Uchiumi T; Kuwano M; Ohtani H; Sawada Y
Br J Pharmacol; 2004 Dec; 143(7):856-64. PubMed ID: 15504753
[TBL] [Abstract][Full Text] [Related]
7. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
9. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein.
Egashira K; Ohtani H; Itoh S; Koyabu N; Tsujimoto M; Murakami H; Sawada Y
Drug Metab Dispos; 2004 Aug; 32(8):828-33. PubMed ID: 15258108
[TBL] [Abstract][Full Text] [Related]
13. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
Iwanaga K; Hayashi M; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
Drug Metab Dispos; 2010 Aug; 38(8):1286-94. PubMed ID: 20463004
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.
Ho PC; Saville DJ; Wanwimolruk S
J Pharm Pharm Sci; 2001; 4(3):217-27. PubMed ID: 11737987
[TBL] [Abstract][Full Text] [Related]
15. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
J Pharm Sci; 2007 Oct; 96(10):2808-17. PubMed ID: 17542018
[TBL] [Abstract][Full Text] [Related]
16. A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.
Paine MF; Widmer WW; Hart HL; Pusek SN; Beavers KL; Criss AB; Brown SS; Thomas BF; Watkins PB
Am J Clin Nutr; 2006 May; 83(5):1097-105. PubMed ID: 16685052
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis of Furanocoumarin, Benzofuran and Coumarin Derivatives Possessing an Inhibitory Effect on Human CYP, and Elucidation of the Inhibitory Mechanism].
Yamaguchi Y
Yakugaku Zasshi; 2017; 137(10):1209-1214. PubMed ID: 28966261
[TBL] [Abstract][Full Text] [Related]
19. [Furanocoumarins contents and cytochrome P450 3A (CYP3A) inhibitory activities of various processed fruit peel products: outflow of 6',7'-Dihydroxybergamottin during processing treatment of peel].
Ishihara M; Toda H; Sunagane N; Ohta T
Yakugaku Zasshi; 2011; 131(5):679-84. PubMed ID: 21532264
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of furanocoumarin derivatives in Kampo extract medicines on P-glycoprotein at the blood-brain barrier.
Iwanaga K; Yoneda S; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
Biol Pharm Bull; 2011; 34(8):1246-51. PubMed ID: 21804213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
